Consumers Push to Advance CV Sciences Suit

@cvsciences

The plaintiffs suing CBD company CV Sciences have asked a federal judge to end an indefinite stay on the suit, arguing that waiting on regulatory clarity from the U.S. Food and Drug Administration (FDA) will not change their claims.

• Two consumers – one from California and one from Arizona – who said they purchased CBD softgels and a CBD spray from CV Sciences in 2018, initially filed the proposed class action suit against the San Diego-based company in December 2019 on grounds that its CBD products were illegally labeled . . .
  

  Log in or become a WeedWeek Member to read this article.